Patents and Licensed Technologies, net

9 Months Ended

Sep. 30, 2012

Patents and Licensed Technologies, net [Abstract]

Patents and Licensed Technologies, net

Note 5

Patents and Licensed Technologies, net:

	September 30, 2012			December 31, 2011
	(unaudited)
Gross Amount beginning of period	$	15,124		$	15,124
Additions		110			-
Translation differences		108			-
Gross Amount end of period		15,342			15,124
Accumulated amortization		(2,225	)		(689	)
Net Book Value	$	13,117		$	14,435

Related amortization expense was $1,530 and $78 for the nine months ended September 30, 2012 and 2011, respectively. An amount of $13,500, included in Patents, represents product and core technologies recorded as part of the purchase price allocation done in connection with the reverse acquisition in order to set the Pre-merged PhotoMedex assets to their respective fair values.

Estimated amortization expense for amortizable patents and licensed technologies assets for the next five years is as follows:

Last three months of 2012	$	509
2013		2,036
2014		2,036
2015		2,029
2016		2,021
Thereafter		4,486
Total	$	13,117